INHIBITION OF INTERLEUKIN-10 SIGNALING IN LUNG DENDRITIC CELLS BY TOLL-LIKE RECEPTOR 4 LIGANDS

REFERENCES

• Fiorentino D F, Zlotnik A, Mosmann T R, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–3822
   PubMed Web of Science ®Google Scholar
• Cassatella M A, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994; 179: 1695–1699
   PubMed Web of Science ®Google Scholar
• Joyce D A, Gibbons D P, Green P, Steer J H, Feldmann M, Brennan F M. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994; 24: 2699–2705
   PubMed Web of Science ®Google Scholar
• Bonfield T L, Konstan M W, Burfeind P, Panuska J R, Hilliard J B, Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13: 257–261
   PubMed Web of Science ®Google Scholar
• Fernandez S, Jose P, Avdiushko M G, Kaplan A M, Cohen D A. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J Immunol 2004; 172: 2613–2620
   PubMed Web of Science ®Google Scholar
• Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 1997; 27: 756–762
   PubMed Web of Science ®Google Scholar
• Tryzmel J, Miskolci V, Castro-Alcaraz S, Vancurova I, Davidson D. Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B. Pediatr Res 2003; 54: 382–386
   PubMed Web of Science ®Google Scholar
• Fiorentino D F, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• Weber-Nordt R M, Riley J K, Greenlund A C, Moore K W, Darnell J E, Schreiber R D. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem 1996; 271: 27954–27961
   PubMed Web of Science ®Google Scholar
• Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt R M. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 1996; 394: 365–370
   PubMed Web of Science ®Google Scholar
• Finbloom D S, Winestock K D. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155: 1079–1090
   PubMed Web of Science ®Google Scholar
• Takeda K, Clausen B E, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10: 39–49
   PubMed Web of Science ®Google Scholar
• Riley J K, Takeda K, Akira S, Schreiber R D. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 1999; 274: 16513–16521
   PubMed Web of Science ®Google Scholar
• Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004; 172: 567–576
   PubMed Web of Science ®Google Scholar
• Rahimi A A, Gee K, Mishra S, Lim W, Kumar A. STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells. J Immunol 2005; 174: 7823–7832
   PubMed Web of Science ®Google Scholar
• Bingisser R M, Holt P G. Immunomodulating mechanisms in the lower respiratory tract: nitric oxide mediated interactions between alveolar macrophages, epithelial cells, and T-cells. Swiss Med Wkly 2001; 131: 171–179
   PubMed Web of Science ®Google Scholar
• Soltys J, Bonfield T, Chmiel J, Berger M. Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(−/−)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J Immunol 2002; 168: 1903–1910
   PubMed Web of Science ®Google Scholar
• Raychaudhuri B, Fisher C J, Farver C F, et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine 2000; 12: 1348–1355
   PubMed Web of Science ®Google Scholar
• Isler P, de Rochemonteix B G, Songeon F, Boehringer N, Nicod L P. Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. Am J Respir Cell Mol Biol 1999; 20: 270–278
   PubMed Web of Science ®Google Scholar
• Martinez J A, King T E, Jr, Brown K, et al. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol 1997; 273: L676–L683, (3 Pt 1)
   PubMed Web of Science ®Google Scholar
• Armstrong L, Jordan N, Millar A. Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes. Thorax 1996; 51: 143–149
   PubMed Web of Science ®Google Scholar
• Sertl K, Takemura T, Tschachler E, Ferrans V J, Kaliner M A, Shevach E M. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med 1986; 163: 436–451
   PubMed Web of Science ®Google Scholar
• Vermaelen K Y, Carro-Muino I, Lambrecht B N, Pauwels R A. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 2001; 193: 51–60
   PubMed Web of Science ®Google Scholar
• Holt P G, Haining S, Nelson D J, Sedgwick J D. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994; 153: 256–261
   PubMed Web of Science ®Google Scholar
• Jahnsen F L, Strickland D H, Thomas J A, et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol 2006; 177: 5861–5867
   PubMed Web of Science ®Google Scholar
• Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769–779
   PubMed Web of Science ®Google Scholar
• Sauter B, Albert M L, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423–434
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Steinbrink K, Enk A H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001; 22: 394–400
   PubMed Web of Science ®Google Scholar
• Agrawal S, Agrawal A, Doughty B, et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003; 171: 4984–4989
   PubMed Web of Science ®Google Scholar
• Lambrecht B N, Salomon B, Klatzmann D, Pauwels R A. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998; 160: 4090–4097
   PubMed Web of Science ®Google Scholar
• Worgall S, Kikuchi T, Singh R, Martushova K, Lande L, Crystal R G. Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells. Infect Immun 2001; 69: 4521–4527
   PubMed Web of Science ®Google Scholar
• Wang B, Zhuang L, Fujisawa H, et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999; 162: 277–283
   PubMed Web of Science ®Google Scholar
• Wakkach A, Cottrez F, Groux H. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol 2001; 167: 3107–3113
   PubMed Web of Science ®Google Scholar
• Wakkach A, Fournier N, Brun V, Breittmayer J P, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18: 605–617
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk A H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772–4780
   PubMed Web of Science ®Google Scholar
• van der Poll T, Marchant A, Keogh C V, Goldman M, Lowry S F. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174: 994–1000
   PubMed Web of Science ®Google Scholar
• Greenberger M J, Strieter R M, Kunkel S L, Danforth J M, Goodman R E, Standiford T J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995; 155: 722–729
   PubMed Web of Science ®Google Scholar
• Du Z, Kelly E, Mecklenbrauker I, et al. Selective regulation of IL-10 signaling and function by zymosan. J Immunol 2006; 176: 4785–4792
   PubMed Web of Science ®Google Scholar
• Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863–869
   PubMed Web of Science ®Google Scholar
• Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001; 31: 3388–3393
   PubMed Web of Science ®Google Scholar
• Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115–122
   PubMed Web of Science ®Google Scholar
• Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167: 5887–5894
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Preston-Hurlburt P, Janeway C A, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394–397
   PubMed Web of Science ®Google Scholar
• Peters I R, Helps C R, Calvert E L, Hall E J, Day M J. Cytokine mRNA quantification in histologically normal canine duodenal mucosa by real-time RT-PCR. Vet Immunol Immunopathol 2005; 103: 101–111
   PubMed Web of Science ®Google Scholar
• Lutz M B, Kukutsch N, Ogilvie A L, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223: 77–92
   PubMed Web of Science ®Google Scholar
• Cochand L, Isler P, Songeon F, Nicod L P. Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am J Respir Cell Mol Biol 1999; 21: 547–554
   PubMed Web of Science ®Google Scholar
• Holt P G, Oliver J, McMenamin C, Schon-Hegrad M A. Studies on the surface phenotype and functions of dendritic cells in parenchymal lung tissue of the rat. Immunology 1992; 75: 582–587
   PubMed Web of Science ®Google Scholar
• Webb T J, Sumpter T L, Thiele A T, Swanson K A, Wilkes D S. The phenotype and function of lung dendritic cells. Crit Rev Immunol 2005; 25: 465–491
   PubMed Web of Science ®Google Scholar
• Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir. J 1999; 14: 309–314
   PubMed Web of Science ®Google Scholar
• Holt P G, Schon-Hegrad M A. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology 1987; 62: 349–356
   PubMed Web of Science ®Google Scholar
• Schon-Hegrad M A, Oliver J, McMenamin P G, Holt P G. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991; 173: 1345–1356
   PubMed Web of Science ®Google Scholar
• Lagranderie M, Nahori M A, Balazuc A M, et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology 2003; 108: 352–364
   PubMed Web of Science ®Google Scholar
• Smit J J, Rudd B D, Lukacs N W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006; 203: 1153–1159
   PubMed Web of Science ®Google Scholar
• Pollard A M, Lipscomb M F. Characterization of murine lung dendritic cells: similarities to Langerhans cells and thymic dendritic cells. J Exp Med 1990; 172: 159–167
   PubMed Web of Science ®Google Scholar
• Steinman R M, Cohn Z A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137: 1142–1162
   PubMed Web of Science ®Google Scholar
• Steinman R M, Lustig D S, Cohn Z A. Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J Exp Med 1974; 139: 1431–1445
   PubMed Web of Science ®Google Scholar
• Swanson K A, Zheng Y, Heidler K M, Zhang Z D, Webb T J, Wilkes D S. Flt3-ligand, IL-4, GM-CSF, and adherence-mediated isolation of murine lung dendritic cells: assessment of isolation technique on phenotype and function. J Immunol 2004; 173: 4875–4881
   PubMed Web of Science ®Google Scholar
• Larsen C P, Ritchie S C, Hendrix R, et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152: 5208–5219
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Sen P, Wallet M, Long B, Baldwin A S, Jr, Tisch R. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood 2004; 104: 1100–1109
   PubMed Web of Science ®Google Scholar
• Nolan K F, Strong V, Soler D, et al. IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J Immunol 2004; 172: 2201–2209
   PubMed Web of Science ®Google Scholar
• Jang M H, Sougawa N, Tanaka T, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol 2006; 176: 803–810
   PubMed Web of Science ®Google Scholar
• Ahmed S T, Ivashkiv L B. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J Immunol 2000; 165: 5227–5237
   PubMed Web of Science ®Google Scholar
• Avdiushko R, Hongo D, Lake-Bullock H, Kaplan A, Cohen D. IL-10 receptor dysfunction in macrophages during chronic inflammation. J Leukoc Biol 2001; 70: 624–632
   PubMed Web of Science ®Google Scholar
• Herrero C, Hu X, Li W P, et al. Reprogramming of IL-10 activity and signaling by IFN-gamma. J Immunol 2003; 171: 5034–5041
   PubMed Web of Science ®Google Scholar
• Park-Min K H, Antoniv T T, Ivashkiv L B. Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology 2005; 210: 77–86
   PubMed Web of Science ®Google Scholar
• Doyle S L, O'Neill L A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006; 72: 1102–1113
   PubMed Web of Science ®Google Scholar
• Ogawa S, Lozach J, Benner C, et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005; 122: 707–721
   PubMed Web of Science ®Google Scholar
• Wietek C, Miggin S M, Jefferies C A, O'Neill L A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J Biol Chem 2003; 278: 50923–50931
   PubMed Web of Science ®Google Scholar
• Bodger K, Wyatt J I, Heatley R V. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 1997; 40: 739–744
   PubMed Web of Science ®Google Scholar
• Castle P E, Hildesheim A, Bowman F P, et al. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J Clin Immunol 2002; 22: 23–27
   PubMed Web of Science ®Google Scholar
• Corne J M, Lau L, Scott S J, Davies R, Johnston S L, Howarth P H. The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med 2001; 163: 1101–1107
   PubMed Web of Science ®Google Scholar
• Gasche C, Bakos S, Dejaco C, Tillinger W, Zakeri S, Reinisch W. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol 2000; 20: 362–370
   PubMed Web of Science ®Google Scholar
• Gravitt P E, Hildesheim A, Herrero R, et al. Correlates of IL-10 and IL-12 concentrations in cervical secretions. J Clin Immunol 2003; 23: 175–183
   PubMed Web of Science ®Google Scholar
• Karttunen R A, Karttunen T J, Yousfi M M, el-Zimaity H M, Graham D Y, el-Zaatari F A. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol 1997; 32: 22–27
   PubMed Web of Science ®Google Scholar
• KleinJan A, Dijkstra M D, Boks S S, Severijnen L A, Mulder P G, Fokkens W J. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 1999; 103: 441–450, (3 Pt 1)
   PubMed Web of Science ®Google Scholar
• Peeters D, Peters I R, Farnir F, Clercx C, Day M J. Real-time RT-PCR quantification of mRNA encoding cytokines and chemokines in histologically normal canine nasal, bronchial and pulmonary tissue. Vet Immunol Immunopathol 2005; 104: 195–204
   PubMed Web of Science ®Google Scholar
• Scavuzzo M C, Rocchi V, Fattori B, et al. Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis. Biomed Pharmacother 2003; 57: 366–371
   PubMed Web of Science ®Google Scholar
• Sohn B H, Moon H B, Kim T Y, et al. Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem. J 2001; 360: 31–38, (Pt 1)
   PubMed Web of Science ®Google Scholar
• van Benten I J, van Drunen C M, Koevoet J L, et al. Reduced nasal IL-10 and enhanced TNFalpha responses during rhinovirus and RSV-induced upper respiratory tract infection in atopic and non-atopic infants. J Med Virol 2005; 75: 348–357
   PubMed Web of Science ®Google Scholar
• Ajuebor M N, Das A M, Virag L, Szabo C, Perretti M. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun 1999; 255: 279–282
   PubMed Web of Science ®Google Scholar
• Moore K W, de Waal Malefyt R, Coffman R L, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765
   PubMed Web of Science ®Google Scholar
• Ji J D, Tassiulas I, Park-Min K H, et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med 2003; 197: 1573–1583
   PubMed Web of Science ®Google Scholar
• MacDonald K P, Pettit A R, Quinn C, Thomas G J, Thomas R. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol 1999; 163: 5599–5607
   PubMed Web of Science ®Google Scholar
• Mongan A E, Ramdahin S, Warrington R J. Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand J Immunol 1997; 46: 406–412
   PubMed Web of Science ®Google Scholar
• Schwacha M G, Schneider C P, Bland K I, Chaudry I H. Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol 2001; 281: C1180–C1187
   Web of Science ®Google Scholar